8 things for spine surgeons to know for Thursday — Nov. 9, 2017

Written by Megan Wood | November 09, 2017 | Print  |

Here are eight things for spinal surgeons to know for Nov. 9, 2017.

Zimmer Biomet Q3 sales drop, led by 2.9% decrease in the Americas
Zimmer Biomet reported net earnings for the quarter of $98.8 million, a 37.8 percent drop over the same period last year. Net sales in the Americas hit $1.1 billion, a 2.9 percent decrease over the same period last year. Interim CEO, Senior Vice President and CFO Daniel Florin reported the revenue decrease in the third quarter was driven by the slow pace of supply recovery in key brands, as well as slower-than-anticipated sales recapture in the U.S.

Dr. Arthur Jenkins to leave academic post at Mount Sinai for independent practice in 2018
Mount Sinai Co-Director of the Neurosurgical Spine Program Arthur Jenkins, MD, is planning to transition into full time private practice on Jan. 1. He will leave his post for private practice, but maintain academic affiliation as faculty, as well as surgical and admitting privileges at Mount Sinai. His new practice will be known as Jenkins NeuroSpine.

Medtronic reports $7.4B in sales, $101.8M in charitable donations for 2017
Medtronic released its 2017 fiscal year integrated performance report, showing the restorative therapies group, which includes the company's spine business, reported $7.4 billion in sales last year. The company donated $101.8 million to charitable causes last year through corporate cash contributions given through Medtronic Foundation, as well as product donations and employee volunteering.

Facts on Sen. Rand Paul's attacker Dr. Rene Boucher
Sen. Rand Paul, R-Ky., MD, was allegedly assaulted by his neighbor, former anesthesiologist Rene Boucher, DO, Nov. 3, NPR reports. Dr. Paul fractured five ribs and suffered a lung contusion in the attack. An advisor to Dr. Paul said although the pain could persist for several months, Dr. Paul would return to the Senate soon, Bowling Green Daily News reports. Read about Dr. Boucher, here.

Mazor reports Q3 revenue at $17.2M, $3.7M net loss
Mazor Robotics reported third quarter revenue at $17.2 million. Mazor received a purchase for 22 Mazor systems, including 19 for Mazor X. Operating loss for the quarter was reported as $3.8 million and net loss hit $3.7 million, or $0.07 per share.

Smith & Nephew Q3 revenue jumps 3%
Smith & Nephew reported 2017 third quarter revenue increased 3 percent, driven by growth in the knee implants and emerging markets. Smith & Nephew's third quarter revenue reached $1.1 million, a 3 percent increase over the same period last year. The company divested its gynecology business in August 2016 and reduced reported growth by 1 percent.

K2M sees $62.7M in Q3 revenue
K2M saw total revenue of $62.7 million in the third quarter of 2017, reflecting a 6 percent year-over-year increase. The company's U.S. complex spine grew 3 percent year-over-year and its U.S. minimally invasive surgery growth of 14 percent year-over-year. K2M experienced a net loss of $8.5 million, compared to $7.9 million in the third quarter the year prior.

Opioid use greatest among spine osteoarthritis patients compared to hip, knee patients
Canada-based University of Toronto researchers examined the opioid use of patients with knee, hip or spine osteoarthritis. Fifteen percent of overall patients reported they "sometimes" used opioids. Spine patients reported the highest opioid use at 40 percent. Females under 65 years old had the greatest overall opioid use. The researchers reported this statistic was particularly reflective of spine patients. 


More articles on spine:
Average neurosurgeon salary totals $543,343 — Which 5 U.S. cities beat the national average?
Overlapping neurosurgeries — Do they affect patient outcomes?
Neurologist Dr. Ralph Northam wins Virginia's governor race: 5 insights

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months